{"id":"W3153448733","doi":"10.30629/0023-2149-2020-98-11-12-739-744","title":"New groups of hypolipidemic medications based on inhibition of proprotein convertase subtilisin/kexin type 9 (PCSK9). Part 1","year":2021,"lang":"en","type":"article","venue":"Clinical Medicine (Russian Journal)","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"PCSK9; Proprotein convertase; Kexin; Alirocumab; Medicine; Evolocumab; LDL receptor; Subtilisin; Pharmacology; Cholesterol; Internal medicine; Lipoprotein; Endocrinology; Biochemistry; Enzyme; Chemistry","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002128681,0.0005580468,0.0004665193,0.001346846,0.0002292065,0.0004270788,0.0003761868,0.0005202975,0.004711649],"category_scores_gemma":[0.0002736045,0.0001353319,0.0006110086,0.0005350709,0.0002282212,0.0006165915,0.0003890961,0.001545265,0.00200127],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001871188,"about_ca_system_score_gemma":0.0002108541,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002841181,"about_ca_topic_score_gemma":0.000792399,"domain_scores_codex":[0.9998715,0.00001733593,0.00001789101,0.00002531878,0.00005288898,0.00001507196],"domain_scores_gemma":[0.9999226,0.00001394031,0.00002174537,0.000004463878,0.00002055571,0.0000167906],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0007958456,0.0008221631,0.001356549,0.002943181,0.0001418356,0.0007655105,0.00008829944,0.0001937627,0.03452171,0.002967812,0.0260149,0.9293883],"study_design_scores_gemma":[0.0007864001,0.004309002,0.01223773,0.0005864125,0.0004043297,0.005938089,0.0000609417,0.0004926624,0.02333481,0.002096228,0.949685,0.00006855068],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0496828,0.9016588,0.00732595,0.005214206,0.00441887,0.0004531988,0.001209464,0.0005253854,0.02951144],"genre_scores_gemma":[0.129106,0.7868825,0.01831961,0.01012368,0.004195017,0.0006633618,0.0028656,0.0000882008,0.04775596],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.004711649,"threshold_uncertainty_score":0.01576209,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05355405999593141,"score_gpt":0.359840569204412,"score_spread":0.3062865092084806,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}